TERT and hepatocellular carcinoma: HCC patients with the combination also show greater TERT promoter methylation levels compared with HCC patients with the variant alone or mutation alone and HCC patients without both the variant and mutation, indicating that the variant combined with the mutation contributes to TERT promoter methylation, which leads to increased TERT expression, HCC mortality, and HCC recurrence.